Skip to main content

Table 3 Literature review of studies evaluating diabetes mellitus or insulin resistance in Klinefelter syndrome

From: Glucose metabolic disorder in Klinefelter syndrome: a retrospective analysis in a single Chinese hospital and literature review

Author, year (ref.)

Number of patients

Age (year)

BMI (kg/m2)

DM (%)

IFG (%)

IR (%)

Diagnosed criteria of IR

Karyotype

Han, 2016 [20]

376

32

24.7 ± 3.9

28 (12.8%)

57 (26.0%)

–

–

47 XXY, 354; 48 XXXY, 2; 48 XXYY, 1; 46 XY/47 XXY, 13; 47 XXY/ 48 XXXY/ 46 XY, 3; 47 XXY/46 XY/46 XX, 1; 47 XXY/48 XXXY, 1; 47 XX, inv. (Y), 1

Yesilova, 2005 [21]

13

22

23.7 ± 4.9

–

–

38.5%

Glucose disposal rates < 4.53 mg/kg/min in hyperinsulinemic euglycemic clamp

All 47 XXY

Bojesen, 2006 [11]

70 (35 without TRT/35 with treatment)

35/39

27.3/25.1

3 (8.5%)/4 (11.4%)

6 (17.1%);7 (20.0%)

–

–

–

Falhammar, 2018 [22]

224

22

26.1 ± 5.3

9.10%

–

–

–

47 XXY, 204; 47 XXY/46 XY, 6; 47 XXY/46 XX, 3; Others and unknown, 5; 46 XX testicular males, 6.

Ota, 2002 [23]

895

43

21.5 ± 4.44

61 (6.8%)

–

–

–

47 XXY, 40; 46 XY/47 XXY, 9; 48 XXYY, 2; 47 XXY/48 XXXY/46 XY, 1; 47 XXY/46 XY/46 XX, 1; unknown, 8.

Bardsley, 2011

[29]

89 Prepubertal Boys

8

–

0

0

20 (24%)

HOMA ≥2.5

47 XXY, 84; 48 XXYY, 1; 47 XXY/46 XY, 2; 46 XX translocation, 1.

Jackson, 1966 [24]

8

–

–

–

1 (12.5%)

–

–

47 XXY, 2; others unknown.

Becker, 1966 [25]

50

38

–

5 (10.0%)

–

–

–

–

Pasquali, 2013 [26]

69

31

27.5

3

16

–

–

–

Nielsen, 1969 [9]

31

–

–

12 (39%); especially 47 XXY/46XY, 4; 47 XXY, 5; 48 XXXY, 3.

–

–

–

47 XXY/46 XY, 4; 47 XXY, 24; 48 XXXY, 3.

Davis, 2016 [27]

96 Prepubertal Boys

–

–

0

0

9 (33.3%), only 27 patients calculated for HOMA

HOMA ≥2.5

47 XXY, 88; 46 XY/47XXY, 2; 48 XXXY, 1; 48 XXYY, 1; 46 XX + SRYtrans, 1.

Davis, 2017 [28]

93 Prepubertal Boys

–

–

–

1

–

–

47 XXY, 89; 46 XY/47 XXY, 2; 48 XXXY or 48 XXYY, 3.

  1. Abbreviations: TRT testosterone replacement therapy, T testosterone, FSH follicle stimulating hormone, LH luteinizing hormone, BMI body mass index, DM diabetes mellitus, IFG impaired fasting glucose, FBG fasting blood glucose, HbA1c hemoglobin A1c, HOMA homeostatic model assessment, IR insulin resistance. Continuous variables were expressed as mean or mean ± standard deviation (SD). HOMA was calculated as a measure of insulin resistance as follows: [fasting blood glucose (mmol/L) × fasting insulin (μIU/mL)]/22.5